Outlook Therapeutics (OTLK) - Shares outstanding

Number of shares outstanding as of November 2024 : 23,227,069

According to Outlook Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 23,227,069. At the end of 2024 the company had 23,227,069 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Outlook Therapeutics from 2024 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	23.22 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Novocure NVCR	108,247,716	366.04%	Jersey
Novavax NVAX	148,379,000	538.82%	🇺🇸 USA
Organovo ONVO	14,663,693	-36.87%	🇺🇸 USA
Orchard Therapeutics ORTX	22,838,856	-1.67%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Outlook Therapeutics (OTLK)

Number of shares outstanding as of November 2024 : 23,227,069